retatrutide clinical trials retatrutide mechanism Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Substack Series 3 of 6:

No, you should not use GLP-1 medications if youre pregnant or planning to become pregnant soon

doi: 10.1002/jnr.22565 167 McGovernSFHunterKHolscherC

Robinson, D

Moreover, unhealthy weight can take a toll on your mental and emotional health

Heres what is true for 2025-2026: Medicare Part D plans are only allowed to cover GLP-1 drugs if they are prescribed for an FDA-approved indication other than just weight loss. For example: Treating type 2 diabetes

In the retatrutide trial data above, dysesthesia jumped from 8.8% at the 9 mg dose to 20.9% at the 12 mg dosea pattern that mirrors whats been seen with another GLP-1 medication at a higher dose